ABUS Swing Pembelian

Arbutus Biopharma CorporationNASDAQ

Deskripsi

⋅ 4 Jan 2021 pukul 20.08

ABUS have a high evaluation above 5.5$ while its currently trading at 3.6 $ expecting profiting from MRNA and PFE patent royalties , currently touching rising trend line and it could be a good entry to start accumulating

Trading ditutup: target tercapai

⋅ 21 Jan 2021 pukul 19.37

take profit at 4 and 4.5

Trend Analysis Wave Analysis

Lebih lanjut